These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4123975)

  • 21. Immunochemistry of the hepatitis B virus: 125I HB Ag ligand.
    Chisari FV; Gerin JL; Edgington TS
    J Immunol; 1974 Aug; 113(2):543-53. PubMed ID: 4845665
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia antigen and its clinical significance].
    Kowalewski J
    Wiad Lek; 1972 Jul; 25(12):1069-72. PubMed ID: 4560543
    [No Abstract]   [Full Text] [Related]  

  • 23. [Qualitative and quantitative radioimmunologic determination of antibodies against hepatitis B surface antigen in hospital personnel].
    Thamer G; Kommerell B
    Verh Dtsch Ges Inn Med; 1975; 81():1350-3. PubMed ID: 1226961
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nature and demonstration of hepatitis B--(Australia)-antigen and its antibody].
    Schober A; Thomssen R
    Internist (Berl); 1973 Nov; 14(11):546-53. PubMed ID: 4204297
    [No Abstract]   [Full Text] [Related]  

  • 25. Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B.
    Trevisan A; Realdi G; Alberti A; Ongaro G; Pornaro E; Meliconi R
    Gastroenterology; 1982 Feb; 82(2):218-22. PubMed ID: 7033035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathology of viral hepatitis in man.
    Reed WD; Eddleston AL; Williams R
    Prog Med Virol; 1974; 17(0):38-76. PubMed ID: 4153910
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoclonal antibody against non-dominant epitopes of HBV e Ag was raised by antigen-antibody co-immunization.
    Yan LC; Jing CY; Huang CF; Ji YY; Yao G; Cai XF; Sun B
    J Biotechnol; 2007 May; 129(4):620-7. PubMed ID: 17408795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pre S1 antigen in different forms of hepatitis B virus infection].
    Brahm J; Hurtado C; Elgueta S; Fuentes C; Velásquez A
    Rev Med Chil; 1995 May; 123(5):567-70. PubMed ID: 8525202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
    Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
    Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Australia antigen in acute and chronic hepatitis].
    Grob PJ; Jemelka HJ; Müller JW
    Schweiz Rundsch Med Prax; 1971 Feb; 60(8):230-7. PubMed ID: 4995012
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B virus antigen: validation and immunologic characterization of low-titer serums with 125 I-antibody.
    Ling CM; Irace H; Decker R; Overby LR
    Science; 1973 Apr; 180(4082):203-5. PubMed ID: 4121028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Ausab test - a radioimmunoassay in the solid phase for the detection of antibodies against HBsAg (author's transl)].
    Lange W; Köhler H; Apodaca J
    Zentralbl Bakteriol Orig A; 1974 Dec; 229(4):423-8. PubMed ID: 4155892
    [No Abstract]   [Full Text] [Related]  

  • 33. Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique.
    Lander JJ; Alter HJ; Purcell RH
    J Immunol; 1971 May; 106(5):1166-71. PubMed ID: 5103349
    [No Abstract]   [Full Text] [Related]  

  • 34. [Presence of macromolecular HBe antigen linked to HBs antigen with masked epitopes in the serum of patients actively reproducing hepatitis B virus].
    Pillot J; Capel F
    C R Seances Acad Sci III; 1981 Jun; 292(21):1133-5. PubMed ID: 6168345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two latex tests for Australia antigen in subjects with and without hepatitis.
    Desmyter J
    Vox Sang; 1973; 24():Suppl:88-94. PubMed ID: 4737048
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heterogeneity of host response to hepatitis B virus].
    Sarno EN; Ruzany F; Vieira LM; Landmann J
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):303-9. PubMed ID: 7167709
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for hepatitis associated antigen by three different methods.
    Thulstrup H; Dybkjaer E
    Vox Sang; 1970; 19(3):234-8. PubMed ID: 4993777
    [No Abstract]   [Full Text] [Related]  

  • 38. Limitations of the radioimmunoassay for hepatitis B antigen.
    Sgouris JT
    N Engl J Med; 1973 Jan; 288(3):160-1. PubMed ID: 4734145
    [No Abstract]   [Full Text] [Related]  

  • 39. [Australia antigen and hepatitis].
    Müller J; Grob PJ
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:107. PubMed ID: 5288594
    [No Abstract]   [Full Text] [Related]  

  • 40. [New radioimmune method in comparison with other methods of hepatitis B antigen identification].
    Schneider W; Sugg U; Frösner GG; Schäuble R; Scheerer U
    Med Welt; 1974 Nov; 25(46):1934-8. PubMed ID: 4456141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.